TUBB2A and Lissencephaly: We found changed levels in DOCK6 (at D3) [55, 56], NPC1 (at D9) [57, 58], CDK5 (at D9) [59, 60], HINT1 (at D9) [61, 62], CSTB (at D9) [63], ACSL4 (at D22) [64, 65], KIF5C (at D22) [66, 67], and TUBB2A (at D22) [68], which are respectively dysregulated in epilepsy, Niemann-Pick disease, mental retardation, cortical dysplasia, lissencephaly, neurotonia, and axonal neuropathy.